Atlas Trials

Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer

Clinical trial NCT06446882 · RECRUITING

Trial details

NCT number
NCT06446882
Sponsor
Fundacio Clinic Barcelona
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2-positive Breast CancerEarly-stage Breast Cancer
Start date
2024-10-11
Primary completion
2028-11-01
Enrollment
304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.